Sterling Biotech is one of the large manufacturers of pharmaceutical gelatin, di-calcium phosphate and APIs including lovastatin, doxorubicin, epirubicin, and daunorubicin
Prior to the government’s new overseas investment rules, bankers learned some hard lessons in the corporate loan business
The Sandesara brothers, promoters of pharmaceutical company Sterling Biotech, fled the country in 2017.
Last month, the federal probe agency had similarly recorded the statement of Ahmed Patel's son-in-law Irfan Siddiqui in the case.
Sterling Biotech, whose promoters Nitin Jayantilal Sandesara and Chetankumar Jayantilal Sandesara are absconding, has a total debt of over Rs 9,000 crore.
Siddiqui's statement was recorded under the Prevention of Money Laundering Act (PMLA) after he was grilled on charges of links with the Sandesara brothers, the owners and promoters of the Vadodara-based company, at an Enforcement Directorate (ED) office here, they added.
The actor and the popular disc jockey (DJ) had been asked to join probe by the Enforcement Directorate (ED) last month as the agency had got evidence that the two were paid some money by the Gujarat-based pharmaceutical group in the past.
One of the country’s top investment banks, SBI Caps was a debt syndication agency for the group’s subsidiary, Sterling Oil Resources.
The actor and the popular disc jockey (DJ) have been asked to depose before the Enforcement Directorate (ED) later this week as it has got evidence that the two were paid some money by the Gujarat-based pharmaceutical group in the past, they said.
The Enforcement Directorate is investigating Sterling Biotech's promoters under The Fugitive Economic Offenders Act, 2016
The National Company Law Tribunal (NCLT) had recently rejected a plea by lenders to withdraw the insolvency proceedings against Sterling Biotech.
Sterling Biotech took loans of over Rs 5,000 crore from a consortium led by Andhra Bank which had turned into non-performing assets.
Multi-crore scams struck India in 2018. Check out the biggest five that made headlines.
Besides Sandesra brother, the court had also issued NBW against Chetan's wife Dipti Sandesara, also a director in the firm, and her brother Hiteshkumar Narendrabhai Patel.
It is alleged that the company took loans of over Rs 5,000 crore from a consortium led by Andhra Bank which had turned into non-performing assets.
Sandesara was arrested in Dubai in August, based on a non-bailable arrest warrant issued by an Indian court.
Speaking to CNBC-TV18, DK Vyas, CEO of SREI Infra, said the acquisition would be part of efforts to recover its loan from Sterlite Port, which is promoted by Sandesara Group, and developing the greenfield port.
M&M | JSPL | Hindalco | Reliance Communications | Tata Power | GPT Infra | NBCC | Hotel Leela | Yes Bank | Edelweiss Financial | Ashok Leyland | Hinduja Foundries | Ajanta Pharma | Shelter Infra | National Fertilizers | Patel Engineering | Rolta India | Educomp | DB Realty | BEML and Supreme Infra are stocks, which are in the news today.
RBL Bank | Kotak Mahindra Bank | DLF | Delta Corp | UltraTech Cement | Reliance Communications | Sterlite Technologies | Ujjivan Financial | PG Electroplast | Phoenix Mills | Jain Irrigation | Indraprastha Medical and Cox & Kings are stocks, which are in the news today.
Sterling Biotech has reported a standalone total income from operations of Rs 87.48 crore and a net loss of Rs 103.82 crore for the quarter ended Dec '15
Sterling Biotech has reported a standalone total income from operations of Rs 108.02 crore and a net loss of Rs 94.21 crore for the quarter ended Sep '15
Sterling Biotech has reported a standalone total income from operations of Rs 118.08 crore and a net loss of Rs 88.48 crore for the quarter ended Jun '15
Ashish Gupta, the MD & Head of Research at Credit –Suisse has drawn up a list of 3700 companies with total debt of USD 505 billion. Of this list, at least USD 55 billion of loans are with companies which have debt higher than their EBIDTA for the last 12 quarters and most of these are still standard in the books of many banks.
Sterling Biotech has reported a standalone total income from operations of Rs 102.06 crore and a net loss of Rs 90.35 crore for the quarter ended Mar '15